Its announcement comes over the heels of an analogous licensing arrangement offered in February to Adastra Labs, which had till now centered on crafting cannabis extracts. Adastra's license also allows it to produce and provide psilocybin and psilocin – hallucinogens a lot more generally called magic mushrooms that develop results just like LSD.I